Results
1
High Growth Stocks
1 companies
argenx
Market Cap: €46.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€745.00
7D
-7.4%
1Y
27.5%
